Skip to main content

Syncona Portfolio Ltd

SEC CIK
0001725042
Latest filing
Aug 6, 2026

Holdings in Q1 2024

Holdings as of Mar 31, 2024, filed May 7, 2024. Long positions only; changes compare share counts with Q4 2023.

Institution overview
Positions
2
−2 vs. Q4 2023
Portfolio value
$150.1M
−$7.70M (−4.9%) vs. Q4 2023
Filed
May 7, 2024
SEC
Holdings of Syncona Portfolio Ltd in Q1 2024
SecurityClassSharesValue% of portfolioShare changeActionHistory
AUTLAutolus Therapeutics plcSPON ADS21,346,829$136.2M90.8%00.0%UnchangedHistory
Achilles Therapeutics PLC00449L102SPONSORED ADS11,086,909$13.9M9.2%00.0%Unchanged–

Sold out since Q4 2023 (2)

Positions held at the end of Q4 2023 that are gone from this filing.

Positions of Syncona Portfolio Ltd sold out since Q4 2023
SecurityClassShares in Q4 2023Value in Q4 2023% of portfolio in Q4 2023History
Freeline Therapeutics Hldgs35655L107SPONSORED ADS1,466,507$9.33M5.9%–
ADAPYAdaptimmune Therapeutics PLCSPONDS ADR1,377,294$1.09M0.7%History